$118Million– No. of Holdings #32
ACUTA CAPITAL PARTNERS, LLC has about 85.9% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 85.9 |
Others | 14.1 |
ACUTA CAPITAL PARTNERS, LLC has about 7.7% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
SMALL-CAP | 41.9 |
MID-CAP | 27.6 |
UNALLOCATED | 16.5 |
LARGE-CAP | 7.7 |
MICRO-CAP | 3.9 |
NANO-CAP | 2.3 |
About 66.7% of the stocks held by ACUTA CAPITAL PARTNERS, LLC either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 66.7 |
Others | 33.3 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
ACUTA CAPITAL PARTNERS, LLC has 32 stocks in it's portfolio. About 65.3% of the portfolio is in top 10 stocks. OCUL proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for ACUTA CAPITAL PARTNERS, LLC last quarter.
Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
AADI | aadi biosciences inc | 2.27 | 1,849,400 | 2,700,130 | unchanged | 0.00 | ||
ACLX | arcellx inc | 1.96 | 42,200 | 2,329,020 | added | 22.32 | ||
AGIO | agios pharma | 2.86 | 78,700 | 3,393,540 | added | 42.41 | ||
APLT | applied therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CELC | celcuity inc | 0.62 | 45,000 | 737,100 | new | |||
CLDX | celldex therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CLRB | cellectar biosciences inc. | 0.15 | 70,500 | 176,250 | reduced | -50.87 | ||
CRBP | corbus pharmaceuticals holdi | 2.46 | 64,500 | 2,918,620 | new | |||
CRNX | crinetics pharmaceuticals | 5.10 | 135,141 | 6,052,960 | added | 72.37 | ||
DYN | dyne therapeutics inc | 6.32 | 212,500 | 7,499,120 | added | 15.18 | ||
HLVX | hillevax inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
IMVT | immunovant inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
INSM | insmed inc | 4.07 | 72,100 | 4,830,700 | added | 16.82 | ||
ITCI | intra-cellular therapies inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
KURA | kura oncology inc. common stock | 2.83 | 163,000 | 3,356,170 | added | 81.11 | ||
LPTX | leap therapeutics inc | 0.32 | 195,000 | 382,200 | reduced | -44.94 | ||
LYRA | lyra therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
MREO | mereo biopharma group pl-adr | 2.05 | 677,000 | 2,437,200 | added | 70.15 | ||
MRSN | mersana therapeutics inc | 2.82 | 1,663,000 | 3,342,630 | reduced | -23.17 | ||
NAMS | newamsterdam pharma co nv | 0.36 | 22,500 | 432,225 | new | |||